Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Piet Ost

264 Results

2023

Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

Valerie FonteyneCharles Van PraetPiet OstBen VannesteNicolaas Lumen

A1 Journal Article in EUROPEAN UROLOGY FOCUS

2022

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie FonteyneCharles Van PraetPiet OstGeert VilleirsSofie VerbekeDaan De MaeseneerElke RammantFlor VerghoteKarel Decaestecker

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Bone health and therapeutic agents in advanced prostate cancer

Renée BultijnckPiet Ost

A1 Journal Article in FRONTIERS IN BIOSCIENCE-LANDMARK

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Aurélie De BruyckerPiet OstValerie Fonteyne

Genomic features of lung-recurrent hormone-sensitive prostate cancer

Kim Van der EeckenSofie VerbekeNicolaas LumenJo Van DorpePiet Ost

A1 Journal Article in JCO PRECISION ONCOLOGY

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke DanckaertMathieu SpaasKatrien VandecasteeleCarlos De WagterPiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

Valerie FonteyneKarel DecaesteckerNicolaas LumenAurélie De BruyckerBieke LambertSofie VerbekeJo Van DorpeRenée BultijnckGeert VilleirsPiet Ost

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Multicentric prospective local treatment of metastatic prostate cancer (LoMP) study

Sarah BuelensFilip PoelaertTom ClaeysElise De BleserBert DhondtWesley VerlaPiet OstKarel DecaesteckerNicolaas Lumen

A1 Journal Article in BJU INTERNATIONAL

Optimizing rehabilitation interventions in men with prostate cancer receiving androgen deprivation therapy

Renée BultijnckPiet OstBenedicte Deforche

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity

Els GoetghebeurDries ReyndersPiet Ost

Unraveling the genomic underpinnings of advanced prostate cancer

Kim Van der EeckenPiet OstJo Van DorpeSofie Verbeke

2021

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial

Flor VerghoteCharles Van PraetPiet OstGeert VilleirsSofie VerbekeDaan De MaeseneerKarel DecaesteckerValerie Fonteyne

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Julie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel MontenFréderic DuprezKatrien VandecasteelePiet Ost

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries ReyndersEls GoetghebeurPieter MestdaghPiet Ost

A1 Journal Article in BMC CANCER

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Kim Van der EeckenSofie VerbekeNicolaas LumenJoke Van DorpePiet Ost

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel MeiresonLiesbeth FerdinandeMarc HaspeslaghPiet OstNora SundahlMathieu SpaasAnnelies DemeyerLieve Brochez

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer : recommendations for advancing precision medicine

Kim Van der EeckenPiet Ost

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Liv VeldemanPiet OstValerie FonteyneYolande LievensMarc Van EijkerenChristel MontenWilfried De Neve

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Emerging prognostic groups across the spectrum of metastatic castration-sensitive prostate cancer : disease outcomes and genomics

Kim Van der EeckenPiet Ost

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor VerghoteLindsay PoppeSofie VerbekePiet OstGeert VilleirsPieter De VisschereDaan De MaeseneerSylvie RotteyCharles Van PraetKarel DecaesteckerValerie Fonteyne

A1 Journal Article in BMC CANCER

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Renée BultijnckBenedicte DeforcheMaarten LievensElke RammantValerie FonteyneKarel DecaesteckerAdelheid SteyaertNicolaas LumenPiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Genetic testing in prostate cancer in clinical practice

Robin de PutterPiet OstKathleen Claes

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Genomic features of lung-recurrent hormone sensitive prostate cancer

Kim Van der EeckenSofie VerbekeNicolaas LumenJo Van DorpePiet Ost

Health-related quality of life in patients with advanced prostate cancer : a systematic review

Pieter De VisscherePiet Ost

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel MeiresonSimon TavernierSofie Van GassenNora SundahlAnnelies DemeyerMathieu SpaasVibeke KruseLiesbeth FerdinandeJo Van DorpeFilomeen HaerynckKarel DecaesteckerSylvie RotteyYvan SaeysPiet OstLieve Brochez

A1 Journal Article in CANCERS

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu SpaasNora SundahlSylvie RotteyDaan De MaeseneerFréderic DuprezVeerle SurmontYolande LievensEls GoetghebeurPiet Ost

Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer

Bram De LaerePiet Ost

A1 Journal Article in CANCERS

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der EeckenMaarten LarmuseauJan VanwelkenhuyzenNicolaas LumenKathleen MarchalJo Van DorpePiet OstBram De LaereSofie Verbeke

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Piet OstKarel Decaestecker

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Spatiotemporal evolution of radiation myositis on 18F-FDG PET/CT following hypofractionated radiotherapy of intramuscular melanoma metastases

David CreytensVibeke KrusePiet Ost

Editorial material

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

An SpiessensEls GoetghebeurDries ReyndersPiet Ost

Editorial material

The mutational landscape of metastatic castration-sensitive prostate cancer : the spectrum theory revisited

Kim Van der EeckenPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Nicolaas LumenElise De BleserSarah BuelensWesley VerlaFilip PoelaertWietse ClaeysValerie FonteyneSofie VerbekeGeert VilleirsSylvie RotteyCharles Van PraetKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenSofie VerbekeJo Van DorpeValerie FonteyneNicolaas LumenBram De LaerePiet Ost

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2020

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Liv VeldemanPiet OstValerie Fonteyne

A1 Journal Article in FRONTIERS IN ONCOLOGY

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De BleserRuben WillemsKarel DecaesteckerLieven AnnemansAurélie De BruyckerValerie FonteyneNicolaas LumenGert De MeerleerPiet OstRenée Bultijnck

A1 Journal Article in CANCERS

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Julie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel MontenFréderic DuprezKatrien VandecasteelePiet Ost

Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Yolande LievensPiet Ost

A1 Journal Article in LANCET ONCOLOGY

Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples

Louise de Schaetzen van BrienenMaarten LarmuseauKim Van der EeckenJan FostierPiet OstKathleen Marchal

A1 Journal Article in BMC MEDICAL GENOMICS

Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D'Amico intermediate and high risk prostate cancer treated with radical prostatectomy : a multi-institutional study

A1 Journal Article in JOURNAL OF UROLOGY

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection

Pieter De VisscherePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review

Elke RammantLisa Van WilderNele PauwelsKarel DecaesteckerCharles Van PraetRenée BultijnckPiet OstSofie VerhaegheAnn Van HeckeValerie Fonteyne

A1 Journal Article in QUALITY OF LIFE RESEARCH

Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy : systematic review of the recent literature

Thomas TaillyPiet OstMarjan WaterloosKarel DecaesteckerValerie FonteyneCharles Van PraetNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan VanwelkenhuyzenKim Van der EeckenBram De LaereKatleen De PreterPiet Ost

Management of patients with advanced prostate cancer : report of the Advanced Prostate Cancer Consensus Conference 2019

A1 Journal Article in EUROPEAN UROLOGY

Nonsurgical salvage local therapies for radiorecurrent prostate cancer : a systematic review and meta-analysis

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Sarah PironVanessa SchelfhoutNick Van LaekenKen KersemansEric AchtenFilip De VosPiet Ost

A1 Journal Article in EJNMMI RESEARCH

PEACE V : salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM) : a study protocol for a randomized controlled phase II trial

Aurélie De BruyckerAn SpiessensPiet Ost

A1 Journal Article in BMC CANCER

PET–CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?

Valerie FonteyneKarel DecaesteckerPieter De VisscherePiet OstGeert Villeirs

A1 Journal Article in CLINICAL AND TRANSLATIONAL IMAGING

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Valerie FonteynePiet Ost

A1 Journal Article in FUTURE ONCOLOGY

Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up

A1 Journal Article in ANNALS OF ONCOLOGY

Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review

A1 Journal Article in ACTA ONCOLOGICA

Reply to Pirus Ghadjar, Thomas Wiegel’s letter to the editor re : Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome, toxicity of stereotactic body radiotherapy, elective nodal radiotherapy. Eur Urol 2019;76:732–9

Elise De BleserPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Shifting the paradigm towards local therapies for oligometastatic prostate cancer

Elise De BleserPiet OstNicolaas Lumen

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Bram De LaerePiet Ost

A1 Journal Article in TRIALS

Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der EeckenNicolaas LumenJan VanwelkenhuyzenWesley VerlaSarah BuelensSofie VerbekeJo Van DorpePiet Ost

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine

Bert DhondtEdward GeeurickxJoeri TulkensJan Van DeunGlenn VergauwenLien LippensPiet OstNicolaas LumenOlivier De WeverAn Hendrix

A1 Journal Article in JOURNAL OF EXTRACELLULAR VESICLES

2019

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Piet OstYolande Lievens

A1 Journal Article in BMC CANCER

Abiraterone and spironolactone in prostate cancer : a combination to avoid

Bert DhondtSarah BuelensElise De BleserPiet OstNicolaas Lumen

A1 Journal Article in ACTA CLINICA BELGICA

Aggressive variants of prostate cancer : are we ready to apply specific treatment right now?

Pieter De VisscherePiet Ost

A1 Journal Article in CANCER TREATMENT REVIEWS

Assessing the role and optimal duration of hormonal treatment in association with salvage radiation therapy after radical prostatectomy : results from a multi-institutional study

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Boosting anticancer immunity with radiotherapy

Nora SundahlPiet OstVibeke KruseKarel Decaestecker

Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial

Sarah BuelensFilip PoelaertElise De BleserBert DhondtWesley VerlaPiet OstKarel DecaesteckerNicolaas Lumen

Current insights in the management of high-risk prostate cancer : still more questions than answers

Valerie FonteynePiet Ost

Editorial material

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert DhondtElise De BleserTom ClaeysSarah BuelensNicolaas LumenJo VandesompeleValerie FonteyneKim Van der EeckenAurélie De BruyckerPiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Exploration of the urinary proteome in the search for new biomarkers for prostate cancer : a promising role for extracellular vesicles

Bert DhondtGlenn VergauwenJan Van DeunEdward GeeurickxLien LippensJoeri TulkensPiet OstOlivier De WeverAn HendrixNicolaas Lumen

External beam radiotherapy only as an alternative for radical cystectomy in highly selected bladder cancer patients

Tom VercauterenNicolaas LumenWerner De GersemBruno SpeleersGeert VilleirsPiet OstPieter De VisschereKarel Decaestecker

A2 Journal Article in BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH

Has the PROPHECY of AR-V7 been fulfilled?

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Hereditary prostate cancer : primetime for genetic testing?

Pieter De VisscherePiet Ost

A1 Journal Article in CANCER TREATMENT REVIEWS

Imaging modalities in synchronous oligometastatic prostate cancer

Piet OstPieter De Visschere

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer

Renée BultijnckElke RammantMartine De MuynckBenedicte DeforcheValerie FonteyneKarel DecaesteckerNicolaas LumenPiet Ost

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Sarah BuelensElise De BleserBert DhondtWesley VerlaKarel DecaesteckerPiet OstValerie FonteyneSylvie RotteyNicolaas Lumen

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?

Tijl VermassenDaan De MaeseneerNicolaas LumenPiet OstSylvie Rottey

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Metastasectomy for visceral and skeletal oligorecurrent prostate cancer

Karel DecaesteckerPiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer : a multicenter study

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Elise De BleserDries ReyndersEls GoetghebeurPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Aurélie De BruyckerElise De BleserKarel DecaesteckerValerie FonteyneNicolaas LumenPieter De VisschereBieke LambertPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Oligometastatic prostate cancer : the game is afoot

Kim Van der EeckenPiet Ost

A1 Journal Article in CANCER TREATMENT REVIEWS

Oligorecurrent prostate cancer limited to lymph nodes : getting our ducks in a row

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke RammantPiet OstBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRenée BultijnckGert De MeerleerCamille SarrazynRoos ColmanValerie Fonteyne

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Filip PoelaertValerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CHIRURGICA BELGICA

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora SundahlJo Van DorpeAnnabel MeiresonLieve BrochezVibeke KrusePiet Ost

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Positive pre-biopsy MRI : are systematic biopsies still useful in addition to targeted biopsies?

Pieter De VisscherePiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Renée BultijnckGiselle PostLiv VeldemanYolande LievensMarc Van EijkerenKatrien VandecasteelePiet OstValerie FonteynePieter DeseyneWilfried De NeveFréderic DuprezMarcus MareelChristel MontenTom VercauterenLeen Paelinck

A1 Journal Article in Radiotherapy and Oncology

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah PironNick Van LaekenYves D'AsselerKlaus BacherKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas LumenEric AchtenBoudewijn BransFilip De Vos

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie Rottey

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie RotteyPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Nora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie RotteyPiet Ost

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Aurélie De BruyckerValerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Re: [Lu-177]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial) : a single-centre, single-arm, phase 2 study

Editorial material

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Karel DecaesteckerValerie FonteynePiet OstGeert Villeirs

A1 Journal Article in BJU INTERNATIONAL

Salvage lymph node dissection for nodal recurrent prostate cancer : a systematic review

Pieter De VisscherePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Aurélie De BruyckerKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN UROLOGY FOCUS

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer

A1 Journal Article in CLINICAL CANCER RESEARCH

The case against the European Medicines Agency's change to the label for radium-223 for the treatment of metastatic castration-resistant prostate cancer

A1 Journal Article in EUROPEAN UROLOGY

Trends in management of oligometastatic hormone-sensitive prostate cancer

A1 Journal Article in CURRENT ONCOLOGY REPORTS

Trends in radical prostatectomy risk group distribution in a European multicenter analysis of 28 572 patients : towards tailored treatment

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Elke RammantValerie FonteyneKarel DecaesteckerRenée BultijnckBenedicte DeforchePiet OstSofie VerhaegheAnn Van Hecke

A1 Journal Article in CLINICAL REHABILITATION

What is oligometastatic prostate cancer?

A1 Journal Article in EUROPEAN UROLOGY FOCUS

2018

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie FonteyneCamille SarrazynGert De MeerleerElke RammantBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRoos ColmanGeert VilleirsPiet Ost

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Elke RammantKarel DecaesteckerRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheValerie Fonteyne

A1 Journal Article in CLINICAL REHABILITATION

AR-V7 predicting treatment response in metastasized prostate cancer : has it peaked?

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study

Renée BultijnckSofie EveraertElke RammantSteven RimbautValerie FonteyneNicolaas LumenKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy) : protocol for a nonrandomized phase II trial

Valerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A2 Journal Article in JMIR RESEARCH PROTOCOLS

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

A1 Journal Article in GENOME MEDICINE

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Lieve BrochezAnnabel MeiresonInes ChevoletNora SundahlPiet OstVibeke Kruse

A1 Journal Article in NATURE COMMUNICATIONS

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer

A1 Journal Article in PROSTATE

Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer

Renée BultijnckInge Van de CaveyeElke RammantSofie EveraertNicolaas LumenKarel DecaesteckerValerie FonteyneBenedicte DeforchePiet Ost

A1 Journal Article in BJU INTERNATIONAL

Combining anticancer drugs with osteoprotective agents in prostate cancer : a contemporary update

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Consensus on molecular imaging and theranostics in prostate cancer

A1 Journal Article in LANCET ONCOLOGY

Curative treatment for muscle invasive bladder cancer in elderly patients : a systematic review

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies : hype or hope?

Hetty HelsmoortelCeline EveraertNicolaas LumenPiet OstJo Vandesompele

A2 Journal Article in NON-CODING RNA RESEARCH

Effects of radiation on the metastatic process

Nora SundahlFréderic DuprezPiet OstWilfried De NeveMarcus Mareel

A1 Journal Article in MOLECULAR MEDICINE

Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis

Annabel MeiresonInes ChevoletEva HulstaertLiesbeth FerdinandePiet OstKaren GeboesVibeke KruseLieve Brochez

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie FonteyneElke RammantPiet OstYolande LievensSylvie RotteyDaan De MaeseneerKarel Decaestecker

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Evaluation and preliminary radiation dosimetry of [18F]PSMA-11 for PET imaging of prostate cancer

Sarah PironNick Van LaekenYves D'AsselerKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas LumenBoudewijn BransFilip De Vos

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Kim De RuyckGert De MeerleerPiet Ost

A1 Journal Article in NATURE COMMUNICATIONS

Focal therapy in localised prostate cancer : real-world urological perspective explored in a cross-sectional European survey

Piet OstPieter De Visschere

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Four- or 5-weeks of radiotherapy for prostate cancer : interim results of a randomized phase 3 trial

Valerie FonteyneElke RammantGert De MeerleerBarbara VanderstraetenNicolaas LumenKarel DecaesteckerPiet Ost

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator

A1 Journal Article in BJU INTERNATIONAL

Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Management of patients with advanced prostate cancer : the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

A1 Journal Article in EUROPEAN UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah BuelensFilip PoelaertBert DhondtValerie FonteynePieter De VisscherePiet OstSofie VerbekeGeert VilleirsSylvie RotteyKarel DecaesteckerNicolaas Lumen

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes with salvage radiotherapy for rising prostate-specific antigen after surgery : a long-term, multi-institutional analysis

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Multicentric prospective local treatment of metastatic prostate cancer (LOMP) trial : interim analysis of clinical outcomes and prognostic factors

Sarah BuelensFilip PoelaertBert DhondtElise De BleserBernard RappePiet OstKarel DecaesteckerNicolaas Lumen

Multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial : interim analysis of clinical outcomes and prognostic factors

Sarah BuelensFilip PoelaertBert DhondtElise De BleserTom ClaeysBernard RappePiet OstKarel DecaesteckerNicolaas Lumen

Multicentrische prospectieve Lokale behandeling van Metastatische Prostaatkanker (LoMP) studie : interim analyse van de klinische uitkomsten en prognostische factoren

Sarah BuelensFilip PoelaertBert DhondtElise De BleserTom ClaeysBernard RappePiet OstKarel DecaesteckerNicolaas Lumen

Open surgery versus primary radiotherapy in T4b sinonasal carcinoma

Jens DebackerWouter HuvenneKatrien BonteWilfried De NevePhilippe DeronPiet OstThibaut Van ZeleHubert VermeerschFréderic Duprez

A1 Journal Article in B-ENT

Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer

Elke RammantPiet OstRenée BultijnckNicolaas LumenKarel DecaesteckerValerie Fonteyne

Pembrolizumab for the treatment of bladder cancer

Nora SundahlSylvie RotteyDaan De MaeseneerPiet Ost

A1 Journal Article in EXPERT REVIEW OF ANTICANCER THERAPY

Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

Annabel MeiresonInes ChevoletEva HulstaertLiesbeth FerdinandePiet OstKaren GeboesMarc De ManDirk Van de PutteVibeke KruseLieve Brochez

A2 Journal Article in ONCOTARGET

Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

Nora SundahlKatrien De WolfVibeke KruseAnnabel MeiresonDries ReyndersEls GoetghebeurMireille Van GeleReinhart SpeeckaertLieve BrochezPiet Ost

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction

Sarah BuelensTom ClaeysBert DhondtFilip PoelaertMatthijs VynckNurten YigitOlivier ThasPiet OstJo VandesompeleNicolaas LumenCandy Kumps

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Prognostische significantie van metastatische symptomen bij nieuw gediagnosticeerd prostaatkanker

Elise De BleserSarah BuelensBert DhondtBernard RappePiet OstKarel DecaesteckerNicolaas Lumen

Prostate cancer-specific PET radiotracers : a review on the clinical utility in recurrent disease

A1 Journal Article in PRACTICAL RADIATION ONCOLOGY

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenBieke LambertGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Stereotactic body radiotherapy for primary prostate cancer

A1 Journal Article in TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenAurélie De BruyckerBieke LambertRenée BultijnckTom ClaeysEls GoetghebeurGeert VilleirsFilip AmeyeGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group

Piet OstYolande Lievens

A1 Journal Article in LANCET ONCOLOGY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De VisschereDries ReyndersMireille Van GeleLieve BrochezPiet Ost

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response

Katrien De WolfNora SundahlMireille Van GeleInes ChevoletReinhart SpeeckaertLieve BrochezPiet Ost

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients

A1 Journal Article in EUROPEAN UROLOGY

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie FonteyneElke RammantPiet OstGert De MeerleerKarel Decaestecker

A1 Journal Article in BMC CANCER

Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer

Filip PoelaertCandy KumpsNicolaas LumenLouis LibbrechtMarleen PraetSylvie RotteyTom ClaeysPiet OstKarel DecaesteckerGert De MeerleerCharles Van Praet

A1 Journal Article in UROLOGIA INTERNATIONALIS

Androgen receptor gene copy number detection using droplet digital PCR and its therapeutic consequences in prostate cancer patients

Sarah BuelensTom ClaeysCandy KumpsBert DhondtFilip PoelaertNurten YigitMatthijs VynckOlivier ThasPiet OstJo VandesompeleNicolaas Lumen

Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?

Tessa KerrePiet OstBarbara De MoerlooseKarim VermaelenLieve BrochezVibeke Kruse

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De WolfSylvie RotteyKarim VermaelenKarel DecaesteckerNora SundahlLizzy De LobelEls GoetghebeurGert De MeerleerNicolaas LumenValerie FonteyneDaan De MaeseneerPiet Ost

A1 Journal Article in RADIATION ONCOLOGY

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

Pieter De VisschereNicolaas LumenPiet OstKarel DecaesteckerGeert Villeirs

A1 Journal Article in CLINICAL RADIOLOGY

Editorial comment

Filip PoelaertPiet OstNicolaas Lumen

Editorial material

Exploring all avenues for radiotherapy in oligorecurrent prostate cancer disease limited to lymph nodes : a systematic review of the role of stereotactic body radiotherapy

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Importance and outcome relevance of central pathology review in prostatectomy specimens : data from the SAKK 09/10 randomized trial on prostate cancer

A1 Journal Article in BJU INTERNATIONAL

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial

Sarah BuelensKarel DecaesteckerValerie FonteynePiet OstSofie VerbekeGeert VilleirsSylvie RotteyNicolaas Lumen

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and therapeutic effect

Filip PoelaertValerie FonteyneKarel DecaesteckerPiet OstSarah BuelensNicolaas Lumen

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy

Aurélie De BruyckerBieke LambertChamberlain MbahGert De MeerleerGeert VilleirsFilip De VosKarel DecaesteckerValerie FonteyneNicolaas LumenPiet Ost

A1 Journal Article in BJU INTERNATIONAL

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter HuyssePiet OstLennart JansAurélie De BruyckerFilip De VosKarel DecaesteckerValerie FonteyneBieke Lambert

A1 Journal Article in DIAGNOSTICS

Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer

Elise De BleserPiet Ost

A1 Journal Article in CURRENT OPINION IN UROLOGY

Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. 'Gotta catch 'em all' or do we? Pokemet approach to metastatic prostate cancer. Eur Urol 2017;72:1–3

A1 Journal Article in EUROPEAN UROLOGY

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol

Elke RammantRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheKarel DecaesteckerValerie Fonteyne

A2 Journal Article in BMJ OPEN

Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer : single institution series of 94 consecutive patients and 124 lymph nodes

A1 Journal Article in CLINICAL GENITOURINARY CANCER

The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Vibeke KruseMax SchreuerKarim VermaelenPiet OstTessa KerreBarbara De MoerlooseLieve Brochez

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Tom ClaeysNicolaas LumenCandy KumpsMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsValerie FonteyneKarel Decaestecker

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR

Sarah BuelensTom ClaeysCandy KumpsBert DhondtFilip PoelaertMatthijs VynckOlivier ThasPiet OstJo VandesompeleNicolaas Lumen

Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial

Dieter BerwoutsKatrien De WolfWilfried De NeveAna Maria Luiza OlteanuBieke LambertBruno SpeleersIngeborg GoethalsIndira MadaniPiet Ost

A1 Journal Article in JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

Whole pelvis radiotherapy for pathological node-positive prostate cancer

Filip PoelaertValerie FonteynePiet OstKarel DecaesteckerGert De MeerleerPieter De VisschereBert DhondtNicolaas Lumen

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

mRNA capture sequencing enabled liquid biopsy screening

Anneleen DecockOlivier De WeverBert DhondtAn HendrixHetty HelsmoortelPieter MestdaghPiet OstJo VandesompeleGlenn Vergauwen

2016

Combinatie van een hoge dosis externe radiotherapie met een simultaan geïntegreerde boost op de dominante intraprostatische lesie : analyse van de genito-urnaire en rectale toxiciteit

Nora SundahlGert De MeerleerGeert VilleirsPiet OstWilfried De NeveNicolaas LumenPieter De VisschereMarc Van Eijkeren

Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity

Nora SundahlGert De MeerleerGeert VilleirsPiet OstWilfried De NeveNicolaas LumenPieter De VisschereMarc Van Eijkeren

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Comparison of the ACR and ESUR PIRADSv1 and v2 in a cohort of 245 patients with histopathological and/or long term follow up

Pieter De VisscherePiet OstTom ClaeysGeert Villeirs

Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) version 1 and 2 in a cohort of 245 patients with histopathological reference and long-term follow-up

Pieter De VisscherePiet OstNicolaas LumenGeert Villeirs

A1 Journal Article in JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Kim De RuyckHubert ThierensPiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate cancer nodal recurrences

Piet OstGert De Meerleer

A1 Journal Article in CLINICAL ONCOLOGY

Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey

Renée BultijnckPieter De VisscherePiet Ost

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence : a multi-institutional analysis

Piet OstGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY

Re: Christopher JD Wallis, Refik Saskin, Richard Choo, et al. Surgery versus radiotherapy for clinically-localized prostate cancer : a systematic review and meta-analysis. Eur Urol 2016;70:21-30

A1 Journal Article in EUROPEAN UROLOGY

Reply from authors re: Vincent Khoo. Is there another bite of the cherry? The case for radical local therapy for oligometastatic disease in prostate cancer. Eur Urol 2016;69:13-4 Oligometastatic prostate cancer: more than just cherry-picking?

Piet OstGert De Meerleer

Editorial material

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer

Pieter De VisscherePiet OstGeert Villeirs

A2 Journal Article in INSIGHTS INTO IMAGING

The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients

Gert De MeerleerPiet OstFilip PoelaertWerner De GersemKarel DecaesteckerPieter De Visschere

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors

Filip PoelaertTom ClaeysPiet OstKarel DecaesteckerGert De MeerleerBert DhondtPieter De VisschereNicolaas Lumen

2015

Acute toxicity and early quality of life after dose intensified salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10

Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy : first results of the randomized trial SAKK 09/10

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial

Dieter BerwoutsKatrien De WolfBieke LambertRenée BultijnckWilfried De NeveLizzy De LobelLennart JansEls GoetghebeurBruno SpeleersAna Maria Luiza OlteanuIndira MadaniIngeborg GoethalsPiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Can we expand active surveillance criteria to include biopsy Gleason 3 + 4 prostate cancer? A multi-institutional study of 2,323 patients

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database

Piet OstPieter De Visschere

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire

Charles Van PraetKarel DecaesteckerTom ClaeysVeerle DecalfGert De MeerleerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CLINICA BELGICA

Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study

Tom ClaeysNicolaas LumenMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsKarel Decaestecker

How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients

Nicolaas LumenPiet OstKarel DecaesteckerPieter De VisschereGert De Meerleer

Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer : a 10-years single centre experience

Piet OstNicolaas LumenGert De Meerleer

A1 Journal Article in ACTA ONCOLOGICA

Management of node only recurrence after primary local treatment for prostate cancer : a systematic review of the literature

A1 Journal Article in JOURNAL OF UROLOGY

Metastasis-directed therapy for oligometastatic prostate cancer recurrence

Karel DecaesteckerNicolaas LumenPiet Ost

Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature

Piet OstKarel DecaesteckerGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY

Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Katrien De WolfPiet OstLieve BrochezInes Chevolet

Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey

Renée BultijnckPieter De VisscherePiet Ost

Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey

Pieter De VisscherePiet Ost

A1 Journal Article in BJU INTERNATIONAL

Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review

Pieter De VisscherePiet Ost

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome

Tom ClaeysCharles Van PraetNicolaas LumenPiet OstGert De MeerleerBieke LambertPieter De VisschereGeert VilleirsKarel Decaestecker

A1 Journal Article in BIOMED RESEARCH INTERNATIONAL

Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling

Pieter De VisscherePiet Ost

A1 Journal Article in ARCHIVOS ESPANOLES DE UROLOGIA

The oncologic role of local treatment in primary metastatic prostate cancer

Pieter De VisscherePiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

Katrien De WolfKarim VermaelenGert De MeerleerBart LambrechtPiet Ost

A1 Journal Article in ONCOIMMUNOLOGY

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study

Filip PoelaertCharles Van PraetGert De MeerleerPiet OstNicolaas Lumen

A1 Journal Article in BIOMED RESEARCH INTERNATIONAL

What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series

Pieter De VisscherePiet Ost

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

2014

Comparison of fluor-18 choline PET/CT versus MRI for detecting bone metastasis in relapsed prostate cancer

Bieke LambertWouter HuysseIngeborg GoethalsGert De MeerleerFilip De VosKarel DecaesteckerPiet Ost

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications

Charles Van PraetKarel DecaesteckerPiet OstPieter De VisschereStephanie VerschuereSylvie RotteyNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial

Annemieke De PuysseleyrJoris Van de VeldeBruno SpeleersTom VercauterenTom Van HoofTom BoterbergWilfried De NeveCarlos De WagterPiet Ost

A1 Journal Article in RADIATION ONCOLOGY

Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions

Sofie De LangheGert De MeerleerKim De RuyckPiet OstWilfried De NeveHubert Thierens

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients

Houssein El SaghireCharlot VandevoordePiet OstGert De MeerleerSarah BaatoutHubert Thierens

A1 Journal Article in INTERNATIONAL JOURNAL OF ONCOLOGY

Multiparametrische prostaat-MRI: klinische toepassingen

Pieter De VisschereWillem OosterlinckGert De MeerleerKarel DecaesteckerNicolaas LumenPiet OstGeert Villeirs

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer

Piet OstKarel DecaesteckerBieke LambertNicolaas LumenGert De Meerleer

A1 Journal Article in PROSTATE

Radiotherapy for renal-cell carcinoma

Gert De MeerleerPiet OstNicolaas LumenMarcus Mareel

A1 Journal Article in LANCET ONCOLOGY

Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058–66

A1 Journal Article in EUROPEAN UROLOGY

Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?

Piet OstRoos ColmanGeert VilleirsKarel DecaesteckerGert De Meerleer

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

Karel DecaesteckerGert De MeerleerBieke LambertTom ClaeysFilip De VosWouter HuyssePiet Ost

A1 Journal Article in RADIATION ONCOLOGY

Salvage pelvic lymph node dissection in prostate cancer: surgical and oncological outcome

Tom ClaeysCharles Van PraetKarel DecaesteckerPiet OstGert De MeerleerPieter De VisschereGeert VilleirsNicolaas Lumen

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Karel DecaesteckerGert De MeerleerBieke LambertWouter HuysseNicolaas LumenPiet Ost

A1 Journal Article in BMC CANCER

To prospectively compare F18-choline PET/CT and axial skeleton MRI for the detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa)

Piet OstWouter HuysseKarel DecaesteckerGert De MeerleerFilip De VosBieke Lambert

What kind of high-grade prostate cancers do we miss with multiparametric magnetic resonance imaging?

Pieter De VisschereLeslie NaesensLouis LibbrechtCharles Van PraetNicolaas LumenPiet OstKarel DecaesteckerGeert Villeirs

2013

Acute and late toxicity after postoperative high-dose pelvic radiotherapy and androgen deprivation for node positive prostate cancer patients: a powerful tool that should be handled with care?

Charles Van PraetNicolaas LumenGert De MeerleerPiet OstKatrien VandecasteeleGeert VilleirsKarel Decaestecker

Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene

Sofie De LangheKim De RuyckPiet OstJoke WerbrouckGert De MeerleerWilfried De NeveHubert Thierens

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Development of a new highly specific targeting probe for non-invasive in vivo visualization of Ncadherin expression in prostate cancer

Christian VanhoveCaroline DumolynPiet OstOlivier De WeverFilip De Vos

Developments in external beam radiotherapy for prostate cancer

Nicolaas LumenPiet OstCharles Van PraetGert De MeerleerGeert Villeirs

A1 Journal Article in UROLOGY

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

Joke WerbrouckPiet OstGert De MeerleerWilfried De NeveEvelien BogaertLaurence BeelsKlaus BacherAnne VralHubert Thierens

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Feasibility study of a Hadron Therapy Centre in Belgium

Lieven AnnemansFrancis ColardynWilfried De NeveFréderic DuprezYolande LievensIndira MadaniPiet OstKatrien VandecasteeleBarbara VanderstraetenLiv VeldemanNick Verhaeghe

High-dose intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: toxicity and early clinical outcome

Nicolaas LumenCharles Van PraetPiet OstKarel DecaesteckerGert De Meerleer

Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases

Gert De MeerleerWilfried De NeveTom BoterbergBruno SpeleersPiet Ost

A1 Journal Article in NEUROLOGICAL SCIENCES

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome

Nicolaas LumenPiet OstCharles Van PraetKatrien VandecasteeleWerner De GersemGeert VilleirsWilfried De NeveKarel DecaesteckerGert De Meerleer

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Imaging treated prostate cancer

Pieter De VisscherePiet OstGert De MeerleerGeert Villeirs

A1 Journal Article in ABDOMINAL IMAGING

Management of locally recurrent disease

Piet OstPieter De VisschereNicolaas LumenGert De Meerleer

Bookchapter in Prostate cancer : a comprehensive perspective

Metastasis-directed therapy for oligmetastic prostate recurrence

Karel DecaesteckerGert De MeerleerBieke LambertNicolaas LumenCharles Van PraetGeert VilleirsPieter De VisscherePiet Ost

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy

Charles Van PraetPiet OstNicolaas LumenGert De MeerleerKatrien VandecasteeleGeert VilleirsKarel Decaestecker

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

Gert De MeerleerBieke LambertNicolaas LumenKarel DecaesteckerGeert VilleirsPiet Ost

A1 Journal Article in CLINICAL GENITOURINARY CANCER

The importance of the number of metastases on prostate cancer-specific survival in patients with noncastrate metastatic prostate cancer following curative treatment

Piet OstKarel DecaesteckerBieke LambertNicolaas LumenGert De Meerleer

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer : results of the Quality Assurance Program of the Randomized Trial SAKK 09/10

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2012

An immobilized antibody targeting N-cadherin facilitates spread of N-cadherin-positive tumour cells

Marc BrackePiet Ost

A1 Journal Article in ANTICANCER RESEARCH

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer

Nicolaas LumenGeert VilleirsPiet OstGert De Meerleer

A2 Journal Article in ADVANCES IN UROLOGY

Detection, localisation and exclusion of high grade prostate cancer with multiparametric MRI: correlation with radical prostatectomy histopathology

Pieter De VisschereGert De MeerleerNicolaas LumenPiet OstWillem OosterlinckGeert Villeirs

Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation

Katrien VandecasteelePiet OstWillem OosterlinckWilfried De NeveGert De Meerleer

A1 Journal Article in PHYTOTHERAPY RESEARCH

High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy

Piet OstGert De MeerleerEvi Nagler

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers

Piet OstGeert VilleirsWillem OosterlinckWerner De GersemCarlos De WagterGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Limited versus extended pelvic lymph node dissection in prostate cancer patients

Charles Van PraetKarel DecaesteckerGeert VilleirsPiet OstGert De MeerleerNicolaas Lumen

Population screening for prostate cancer: an overview of available studies and meta-analysis

Nicolaas LumenGert De MeerleerPiet OstGeert VilleirsPieter De VisschereWillem Oosterlinck

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Prostate MRI at 3.0T versus endorectal 1.5T: comparison of spectral and overall image quality

Pieter De VisschereGert De MeerleerKarel DecaesteckerPiet OstGeert Villeirs

Salvage radiotherapy : a plea for dose-escalation with intensity-modulated radiotherapy

Piet OstGert De Meerleer

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

Gert De MeerleerBieke LambertNicolaas LumenKarel DecaesteckerGeert VilleirsPiet Ost

Screening and early diagnosis of prostate cancer: an update

Nicolaas LumenGert De MeerleerPieter De VisscherePiet OstWillem OosterlinckGeert Villeirs

A1 Journal Article in ACTA CLINICA BELGICA

Surgical outcome of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre

Charles Van PraetNicolaas LumenKarel DecaesteckerGert De MeerleerWillem OosterlinckPiet OstAlexandre Mottrie

Whole abdominopelvic radiotherapy (WAPRT) using intensity modulated arc therapy (IMAT) as palliation for chemotherapy-resistant ovarian cancer

Katrien VandecasteeleAmin MakarPhilippe TummersHannelore DenysRudy Van den BroeckePieter De VisscherePiet OstGert De Meerleer

2011

A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer

Piet OstWerner De GersemWilfried De NeveGert De Meerleer

A1 Journal Article in CLINICAL ONCOLOGY

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer

Piet OstWillem OosterlinckGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy

Piet OstGert De MeerleerWerner De Gersem

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines

Piet OstGert De MeerleerTom VercauterenWerner De GersemLiv VeldemanKatrien VandecasteeleGeert Villeirs

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?

Gert De MeerleerPiet Ost

Editorial material

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study

Piet OstBruno SpeleersGert De MeerleerWilfried De NeveGeert VilleirsWerner De Gersem

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience

Gert De MeerleerKatrien VandecasteelePiet OstHannelore DenysAmin MakarBruno SpeleersSimon Van BelleRudy Van den BroeckeWilfried De Neve

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2010

Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperbert, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30

Piet OstGert De Meerleer

A2 Journal Article in EUROPEAN UROLOGY

2009

Adjuvant High-Dose Intensity-Modulated Radiotherapy after Radical Prostatectomy for Prostate Cancer: Clinical Results in 104 Patients

Piet OstGeert VilleirsNicolaas LumenWillem OosterlinckGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY

Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001)

Piet OstWilfried De NeveWerner De GersemCarlos De WagterKatrien VandecasteeleFréderic DuprezGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2008

F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma - A case report

Piet OstSylvie RotteyTom BoterbergIngeborg Goethals

A1 Journal Article in Journal of Thoracic Imaging

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy

Gert De MeerleerGeert VilleirsNicolaas LumenPiet OstKatrien VandecasteeleWilfried De Neve

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2005

Postoperative intensity-modulated radiotherapy in sinonasal carcinoma - Clinical results in 39 patients

Tom BoterbergPiet OstLuc VakaetFréderic DuprezHubert VermeerschWilfried De Neve

A1 Journal Article in CANCER

2002

Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: Treatment results for 47 patients

Tom BoterbergPiet OstHubert VermeerschKatrien BonteWilfried De Neve

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome?

Tom BoterbergPiet OstWilfried De Neve

A1 Journal Article in Radiotherapy and Oncology